Fact-checked by Grok 2 weeks ago

PVCS

Premature ventricular contractions (PVCs) are extra heartbeats that originate in the ventricles—the lower chambers of the heart—rather than the atria, interrupting the normal cardiac rhythm. These ectopic beats occur when an electrical impulse prematurely triggers a ventricular contraction, often resulting in a brief pause before the next regular heartbeat. PVCs are highly prevalent, affecting up to 75% of the general population at some point on , and are typically benign in healthy individuals without underlying . While many people experience no symptoms, PVCs can sometimes cause sensations of fluttering or skipped beats, particularly if frequent or associated with heart conditions. In those with structural heart disease, they may indicate or contribute to more serious arrhythmias. ranges from lifestyle modifications to medications or , depending on symptoms and underlying causes, with a generally favorable in healthy individuals.

Definition and characteristics

Definition

Premature ventricular contractions (PVCs), also known as premature ventricular complexes or ventricular premature beats (VPBs), are ectopic heartbeats that originate within the ventricles, typically from or ventricular myocytes, rather than the . These extra beats disrupt the normal cardiac rhythm by occurring earlier than the next expected sinus beat, resulting in a premature of the ventricles that bypasses the usual conduction pathway through the atria. PVCs are classified as a form of ventricular extrasystole, representing abnormal electrical impulses arising distal to the His-Purkinje system. In contrast to premature atrial contractions (PACs), which arise from ectopic foci in the atria and conduct through the to the ventricles, PVCs initiate directly in the ventricular myocardium or Purkinje network, often producing a wider on due to altered ventricular activation. This distinction is fundamental, as PACs primarily affect supraventricular structures, whereas PVCs involve subatrial origins and can more readily lead to hemodynamic effects if frequent. PVCs are commonly benign in individuals without underlying heart disease, occurring sporadically without , but frequent PVCs—defined as more than 10-20% of total beats—may signal potential structural or ischemic cardiac issues requiring further evaluation. Historically, the terminology has evolved from ventricular premature beats to the more precise premature ventricular complexes, reflecting their role as isolated ectopic events rather than full contractions in some contexts.

Electrocardiographic features

Premature ventricular contractions (PVCs) are identified on the electrocardiogram (ECG) by a premature that is typically wide and morphologically distinct from the QRS. The QRS duration is usually greater than 120 ms, often exhibiting a bizarre, notched, or slurred appearance due to ventricular origin without conduction through the His-Purkinje system. Unlike supraventricular premature beats, PVCs are not preceded by a , although a retrograde P wave may occasionally appear after the QRS, inverted in leads , III, and aVF. A hallmark of isolated PVCs is the compensatory pause that follows, where the interval from the sinus beat before the PVC to the sinus beat after equals twice the normal sinus RR interval, resulting from the PVC's failure to reset the sinus node due to retrograde concealment in the . This full pause contrasts with noncompensatory pauses seen in other arrhythmias, such as premature atrial contractions. PVCs often show discordant ST-segment and T-wave changes, with the ST-T complex directed opposite to the main QRS deflection, reflecting abnormal secondary to the altered activation sequence. These repolarization abnormalities are prominent and help distinguish PVCs from aberrant supraventricular beats. The of the PVC QRS provides clues to its ventricular origin: a (LBBB)-like pattern, with a predominantly negative QRS in lead , suggests a right ventricular site, such as the ; conversely, a (RBBB)-like pattern, with a positive QRS in , indicates a left ventricular origin. Multifocal PVCs display varying morphologies from different foci. Fusion beats occur when a PVC partially coincides with a sinus beat, producing a QRS morphology intermediate between the sinus and PVC patterns, due to simultaneous activation from both sources. Interpolated PVCs, less common, appear between two sinus beats without a compensatory pause, as the sinus impulse conducts through the despite the PVC, potentially increasing risk with high burden.

Signs and symptoms

Typical manifestations

The most common symptom of premature ventricular contractions (PVCs) is , often described as a sensation of skipped beats, pounding, fluttering, or jumping in the chest. These sensations arise from the abrupt early contraction of the ventricles, which interrupts the normal heart rhythm and increases awareness of cardiac activity. Many individuals with PVCs experience no symptoms at all, with studies using 24- to 48-hour Holter detecting PVCs in approximately 50% to 75% of healthy who have them on evaluation. This high rate of unawareness underscores that PVCs are often incidental findings rather than clinically disruptive events in otherwise healthy individuals. or can occur due to brief hemodynamic instability caused by the irregular rhythm, particularly when PVCs reduce momentarily. or reduced exercise tolerance may also develop in cases involving higher PVC frequency, as the irregular beats impair overall cardiac efficiency during . The likelihood and intensity of symptoms often correlate with PVC frequency; isolated PVCs are frequently unnoticed, whereas patterns like —where every other beat is a PVC—tend to be more perceptible and bothersome due to their repetitive nature. Common benign triggers such as consumption can heighten symptom awareness in susceptible individuals.

Associated conditions

Certain symptoms accompanying premature ventricular contractions (PVCs) can indicate underlying structural heart disease and warrant prompt evaluation. Syncope or near-syncope, particularly when occurring during physical exertion, serves as a critical , as it may reflect impaired due to structural abnormalities such as or valvular disease. In such cases, these episodes suggest that PVCs are not isolated but part of a broader arrhythmogenic substrate that compromises hemodynamic stability. Chest pain associated with PVCs often presents in an angina-like manner and points to myocardial ischemia as a potential etiology, where reduced coronary perfusion exacerbates the ectopic beats. This symptom typically involves pressure or discomfort in the chest, neck, or arms, distinguishing it from benign sensations and necessitating assessment for coronary artery disease. Shortness of breath (dyspnea) in the presence of PVCs frequently signals coexisting , where frequent ectopic activity impairs ventricular filling and ejection, leading to pulmonary congestion. Alternatively, it may relate to pulmonary conditions that heighten arrhythmic susceptibility, such as , though cardiac origins predominate in symptomatic cases. Exertional symptoms, including worsening or during , heighten concern for underlying , as exercise unmasks latent myocardial dysfunction triggered by PVCs. These manifestations prompt comprehensive and to identify conditions like arrhythmogenic right ventricular , where PVC burden correlates with progressive . Additional red flags include PVCs in individuals with a family history of sudden cardiac death or known channelopathies, such as , which elevate the risk of life-threatening arrhythmias beyond isolated ectopy. These familial associations necessitate and targeted screening to mitigate hereditary risks.

Causes and risk factors

Benign triggers

Premature ventricular contractions (PVCs) in otherwise healthy individuals can often be provoked by reversible, non-pathological factors that transiently alter or autonomic balance. These benign triggers are common and typically do not indicate underlying heart disease, though they may increase PVC frequency in susceptible people. Identifying and mitigating such triggers forms the basis of initial management strategies. Lifestyle factors such as excessive intake, consumption, use, and illicit drug use are well-established precipitants of PVCs. , found in , , and energy drinks, stimulates the , potentially increasing adrenergic tone and PVC occurrence. Similarly, can disrupt cardiac ion channels and autonomic regulation, while from elevates catecholamine levels, and illicit drugs like or amphetamines provoke PVCs through intense sympathetic stimulation. Emotional states including , anxiety, and also contribute by elevating circulating catecholamines, which enhance myocardial . Acute or anxiety activates the sympathetic response, mimicking exercise-induced changes and provoking ectopic beats. Sleep deprivation similarly disrupts autonomic , increasing PVC burden through sustained adrenergic surges. Physiological triggers encompass certain activities or bodily states that modulate vagal or sympathetic tone. In some healthy individuals, exercise—particularly during phases—can elicit PVCs due to shifting autonomic and residual catecholamine effects. Post-meal vagal stimulation from gastric distension may also induce PVCs via enhanced parasympathetic activity, while positional changes, such as assuming a , can alter venous return and trigger ectopics through autonomic shifts. Certain medications can provoke PVCs by stimulating the cardiovascular system. Decongestants containing increase sympathetic activity, raising and ectopic potential. Beta-agonist asthma inhalers, like albuterol, similarly cause transient and PVCs through adrenergic stimulation. Some antidepressants, particularly tricyclics, may contribute via or noradrenergic effects. Transient electrolyte imbalances, such as mild or hypomagnesemia arising from dietary deficiencies, , or gastrointestinal losses, can lower the threshold for ventricular ectopy. Low disrupts , while impairs function, both fostering PVCs in the absence of severe . Correcting these through dietary adjustments or supplementation often reduces episodes. Eliminating or reducing exposure to these benign triggers is a first-line conservative approach to managing PVCs in healthy individuals.

Underlying cardiac conditions

Premature ventricular contractions (PVCs) are frequently associated with underlying structural heart diseases that predispose to ectopic ventricular activity by altering myocardial substrate or conduction pathways. Ischemic heart disease, particularly following myocardial infarction, increases PVC occurrence due to scar tissue facilitating re-entrant circuits. Cardiomyopathies, including dilated and hypertrophic forms, disrupt normal ventricular depolarization and are common substrates for PVCs, with frequent ectopy potentially exacerbating left ventricular dysfunction. Valvular heart diseases, such as mitral valve prolapse, can trigger PVCs through mechanical stretch or associated fibrosis affecting the papillary muscles. Congenital heart defects, including those leading to dilated cardiomyopathy, heighten PVC risk by imposing chronic hemodynamic stress on the ventricles. Inflammatory cardiac conditions also contribute to PVC pathogenesis by causing myocardial irritation and . , often resulting from viral infections or post-viral immune responses, induces that lowers the threshold for ventricular ectopy and may manifest as frequent PVCs. Electrolyte imbalances and metabolic derangements can precipitate or worsen PVCs in the context of cardiac vulnerability. Severe disrupts , promoting premature beats, while accelerates myocardial excitability through excess catecholamines. , as seen in acute ischemic or respiratory events, further sensitizes the myocardium to ectopic activity. Demographic factors influence PVC prevalence in the presence of cardiac . PVCs are more common among elderly men and individuals with a history of prior , reflecting cumulative structural damage and age-related . In patients with structural heart disease, PVCs serve as markers for substrates and are linked to increased risk of sudden cardiac death. Frequent PVCs exceeding 500 per 24 hours, particularly in ischemic or cardiomyopathic hearts, correlate with higher mortality, as evidenced by long-term cohort studies.

Pathophysiology

Ectopic mechanisms

Premature ventricular contractions (PVCs) arise from ectopic mechanisms that disrupt normal , primarily through enhanced , re-entrant circuits, and triggered activity. These processes involve abnormal depolarization events in ventricular myocytes or specialized conduction tissues, often exacerbated by structural or ionic alterations in the heart. While the exact mechanism can vary by clinical context, understanding these pathways is essential for distinguishing benign from malignant ectopy. Enhanced refers to abnormal spontaneous in or ventricular myocytes, where the slope of phase 4 diastolic increases, leading to premature firing. This occurs when the threshold for initiation is lowered due to shifts in activity, such as enhanced inward currents during . In , this mechanism is particularly prominent, as these cells possess intrinsic properties that can become abnormally activated under pathological conditions like ischemia or . Re-entrant circuits in PVCs typically involve unidirectional and slow conduction within ventricular tissue, creating a self-sustaining loop of electrical activity. This requires a substrate with heterogeneous refractoriness or conduction velocity, often in scarred or fibrotic areas, where a premature encounters a block in one direction but propagates slowly in the other, allowing reexcitation of previously depolarized tissue. Such circuits can initiate isolated PVCs or degenerate into sustained arrhythmias if the loop persists. Triggered activity manifests as early afterdepolarizations (EADs) or delayed afterdepolarizations (DADs), driven by intracellular calcium overload that reactivates depolarizing currents during or after the action potential. EADs arise from prolonged phases, often linked to reactivation of L-type calcium channels, while DADs result from spontaneous calcium release, activating the sodium-calcium exchanger to generate transient inward currents. Calcium overload, induced by conditions like or adrenergic stimulation, lowers the threshold for these afterdepolarizations to trigger PVCs. Altered gap junction function plays a key role in facilitating ectopic foci by impairing intercellular conduction and creating isolated zones of hyperexcitability. Reduced expression or uncoupling of connexin-43 s leads to focal areas of poor electrical coupling, allowing abnormal depolarizations in small myocyte clusters to escape suppression and propagate as PVCs. This mechanism is evident in diseased hearts where heterogeneous distribution promotes source-sink mismatches, enhancing the likelihood of ectopic initiation. The , particularly sympathetic activation, influences PVC mechanisms by lowering the threshold for ectopic firing through β-adrenergic stimulation. Sympathetic surges increase cyclic AMP levels, enhancing calcium handling and automaticity in while promoting afterdepolarizations via calcium overload. This modulation can precipitate PVCs during stress or exercise, underscoring the interplay between neural input and intrinsic .

Common origins

The most common site of origin for premature ventricular contractions (PVCs) is the right (RVOT), accounting for 70-80% of idiopathic cases. These PVCs typically exhibit a (LBBB) morphology with an inferior axis on , reflecting their emergence from the subendocardial region of the RVOT. PVCs originating from the left (LVOT) are less frequent, comprising approximately 10-20% of outflow tract-related cases. They share an inferior axis similar to RVOT PVCs but demonstrate distinct precordial transitions, often with earlier R-wave progression or a narrower in the right precordial leads, aiding in differentiation from right-sided origins. Fascicular PVCs arise from the Purkinje system within the left ventricular fascicles, representing a smaller subset of idiopathic arrhythmias. These contractions produce a relatively narrow due to rapid conduction through the specialized conduction tissue and are characteristically sensitive to verapamil, indicating a calcium-dependent mechanism. PVCs from the s, particularly in the left ventricle, are associated with and occur more frequently in patients with underlying . These sites contribute to recurrent ectopy in structural heart disease, with origins often linked to fibrotic changes in the papillary muscle heads. In patients with ischemic heart disease, scar-related PVCs commonly emerge from post-infarct zones, where heterogeneous creates substrates for arrhythmogenesis. These origins account for a significant portion of PVC burden in such populations, frequently involving re-entrant circuits within the infarct border zone as explored in the section.

Diagnosis

Initial assessment

The initial assessment of suspected premature ventricular contractions (PVCs) begins with a detailed to identify symptom onset, such as , , or , along with their frequency and potential triggers like , , or exercise. Family history of arrhythmias or sudden cardiac death is also elicited to screen for inherited conditions. A thorough follows, focusing on including an irregular pulse and cardiac to detect suggestive of valvular or signs of such as jugular venous distension or . Thyroid enlargement is specifically checked due to its association with , a known PVC trigger. Routine (ECG) with a 12-lead recording is essential to confirm PVC presence, assess for origin (e.g., left or right ventricular), and exclude acute issues like ischemia or other . A short strip (30-50 seconds) may accompany this to evaluate PVC . Blood tests are ordered to identify reversible causes, including serum electrolytes ( and magnesium) to rule out imbalances, for , and levels to assess for myocardial ischemia if symptoms warrant. Echocardiography is recommended to evaluate for structural heart disease, such as or valvular abnormalities, in most patients referred for PVCs. Risk stratification integrates these findings to assess overall cardiovascular risk, particularly in patients with frequent PVCs or indicators of structural heart disease, guiding further .

Advanced

Advanced monitoring techniques play a crucial role in quantifying the frequency, patterns, and burden of premature ventricular contractions (PVCs) over extended periods, enabling more precise risk stratification beyond initial electrocardiographic assessment. These methods are particularly valuable for patients with suspected symptomatic or high-burden PVCs, where short-term recordings may underestimate true prevalence. By capturing ambulatory data during daily activities, advanced monitoring helps correlate PVCs with symptoms and guides decisions on intervention, such as when PVC burden exceeds thresholds associated with risk. Holter monitoring involves continuous electrocardiographic (ECG) recording using a portable device worn by the patient for 24 to 48 hours, providing a comprehensive assessment of daily PVC burden. This technique is considered the gold standard for evaluating PVC frequency in symptomatic patients, as it captures a full day's worth of cardiac activity, including variations during , exercise, and . PVCs are common in the general , with rates of 30-75% on 24-hour Holter monitoring in healthy individuals, though high burdens (>10%) are uncommon and may warrant evaluation if structural heart disease is absent. Event recorders, also known as ECG monitors, extend surveillance to 14 to 30 days for outpatient use, specifically targeting symptomatic episodes that occur infrequently. These devices activate manually or automatically upon detecting irregularities, allowing correlation between patient-reported symptoms like and actual PVC occurrences. They are particularly useful when Holter monitoring fails to capture events, offering higher diagnostic yield for intermittent PVCs without the need for continuous wear discomfort. Clinical guidelines endorse event recorders for up to 30 days in patients with unexplained symptoms, improving symptom-rhythm correlation. Implantable loop recorders (ILRs) provide long-term for up to three years, implanted subcutaneously to detect rare or infrequent PVC events that evade shorter-term devices. These devices continuously record ECG data and store episodes triggered by patient activation or predefined criteria, such as high ventricular rates. ILRs are indicated for patients with infrequent symptoms where remains elusive after noninvasive , with life supporting extended follow-up in high-risk cohorts. Studies show diagnostic yields of 30-50% for arrhythmias in unexplained . Wearable devices, including smartwatches equipped with photoplethysmography and single-lead ECG capabilities, offer noninvasive, real-time detection of irregular rhythms suggestive of PVCs, validated against Holter monitoring in clinical studies. These consumer-grade tools can identify premature contractions with of approximately 85-95%, particularly for frequent events, though they may underperform for isolated PVCs compared to professional monitors. Validation trials have confirmed their utility in ambulatory settings, with algorithms detecting PVCs in sequences and estimating burden, though they are best used as adjuncts to confirm irregularities prompting formal evaluation. PVC burden is calculated as the percentage of PVCs relative to the total number of ventricular beats over the monitoring period, serving as a key metric for assessing clinical significance. A burden exceeding 10% to 20% is associated with increased risk of PVC-induced and often warrants intervention, such as antiarrhythmic therapy or , particularly if symptoms or ventricular dysfunction are present. Thresholds vary by study, but burdens above 10% on 24-hour monitoring predict adverse outcomes, while those over 20% heighten urgency for suppression.

Treatment

Conservative approaches

Conservative management of premature ventricular complexes (PVCs) focuses on non-invasive strategies to mitigate symptoms and reduce PVC frequency in patients without structural heart disease or significant burden, prioritizing the identification and elimination of modifiable risk factors. This approach is particularly suitable for asymptomatic individuals or those with low PVC burden, aiming to improve overall cardiac without pharmacological or procedural interventions. Trigger avoidance plays a central role in conservative strategies, as certain stimulants and behaviors can exacerbate PVCs. Patients are advised to limit or eliminate , , and intake, as these substances have been associated with increased PVC occurrence; is especially beneficial for long-term risk reduction. Additionally, managing emotional stress through relaxation techniques is recommended, given its potential to provoke arrhythmias in susceptible individuals. Addressing reversible physiological triggers, such as imbalances or acute ischemia, further supports this non-invasive framework. Lifestyle modifications complement trigger avoidance by promoting sustained cardiac wellness. Regular moderate exercise, tailored to avoid high-intensity activities that may induce PVCs, can enhance and potentially decrease burden. Weight management to achieve an ideal is encouraged, as correlates with higher PVC prevalence. Prioritizing —ensuring 7-9 hours of quality rest nightly—also contributes to overall autonomic balance and symptom control. For patients with low-burden PVCs, reassurance is a key component, emphasizing that isolated PVCs in the absence of underlying heart disease pose minimal risk and often do not require . Periodic through follow-up electrocardiograms (ECGs) or Holter is advised to track PVC and ventricular function, with re-evaluation prompted by new symptoms. Beta-blockers may be considered briefly if symptoms persist despite these measures, though details on are addressed elsewhere. The 2022 () guidelines underscore conservative management for PVC burden less than 10% in patients without structural heart disease, recommending observation with regular assessments of left ventricular (LVEF) and burden as a Class I indication. This approach avoids unnecessary escalation while ensuring timely detection of progression.

Interventional therapies

Interventional therapies for premature ventricular contractions (PVCs) primarily encompass and , reserved for cases where conservative measures fail to alleviate symptoms or mitigate risks such as . typically begins with beta-blockers, such as metoprolol, which reduce sympathetic drive and suppress PVC frequency in idiopathic cases originating from the right (RVOT). Beta-blockers are recommended as first-line agents due to their favorable safety profile, though their efficacy is modest, with clinically meaningful reductions in 12-24% of patients. For patients with structurally normal hearts and persistent symptoms, class I antiarrhythmics like are indicated, particularly for RVOT PVCs, as they target sodium channels to suppress ectopic activity without significant proarrhythmic effects in this population. According to guidelines, carries a class IIa recommendation for symptomatic idiopathic PVCs when is not preferred. A 2024 randomized trial (ECTOPIC) demonstrated reduced PVC burden by an estimated 10.6 percentage points compared to 2.4 for metoprolol in patients with frequent symptomatic PVCs. Catheter ablation serves as a curative option by delivering radiofrequency energy to ablate ectopic foci, achieving acute success rates greater than 80% for RVOT-origin PVCs through precise mapping and targeting of premature activation sites. Long-term freedom from PVC recurrence post-ablation reaches 83-88% in RVOT cases, with procedural efficacy enhanced by three-dimensional electroanatomic mapping systems. Ablation is particularly effective for monomorphic PVCs. Indications for these interventions include a PVC burden exceeding 10-20% of total beats, which correlates with increased risk of PVC-induced , or persistent symptoms to initial management. In patients developing left ventricular dysfunction attributable to high-burden PVCs (>15%), is preferred over due to higher rates of PVC suppression and cardiomyopathy reversal. Therapy escalation is also warranted for symptomatic individuals with burdens as low as 10%, prioritizing in those with structural heart disease absence to prevent progression to . Complications from are infrequent, occurring in 0-5% of procedures, with risks including (1-2% in para-Hisian sites) and cardiac (<1%). Overall major adverse events remain low at 2.7%, underscoring the procedure's safety profile when performed by experienced operators. Recent advances include cryoablation for PVCs near critical structures like perivalvular regions, offering reversible lesions that minimize conduction system injury compared to radiofrequency methods. A 2019 study demonstrated successful cryoablation of para-Hisian PVCs without , achieving complete suppression in challenging cases. The 2019 HRS/EHRA/APHRS/LAHRS expert consensus highlights cryoablation's role in high-risk sites, with acute success rates approaching 95% and reduced recurrence in perivalvular origins.

Prognosis and complications

Short-term outcomes

In individuals without structural heart disease, premature ventricular contractions (PVCs) are typically benign, with most episodes resolving spontaneously or upon elimination of identifiable triggers such as caffeine intake, stress, alcohol consumption, or electrolyte disturbances, and they carry no acute mortality risk. A 2020 American Heart Association scientific statement confirms that asymptomatic PVCs in otherwise healthy individuals do not increase the risk of short-term cardiac events compared to the general population, supported by long-standing observations from cohort studies like the 1985 Kennedy et al. analysis of 70 patients with frequent PVCs showing excellent short-term prognosis. For symptomatic patients with low PVC burden (typically <10% of total beats), lifestyle modifications including avoidance of stimulants, tobacco cessation, stress reduction, and adequate sleep can achieve symptom relief, often leading to substantial reduction in PVC frequency within weeks to months. Catheter ablation for idiopathic PVCs offers high acute success, eliminating the targeted PVC morphology in approximately 80% of procedures, with overall success rates reaching 80-95% across multicenter studies of outflow tract origins. Post-intervention efficacy is evaluated through repeat 24-hour Holter monitoring, which quantifies PVC burden reduction—typically aiming for <5% of total beats—to confirm symptom resolution and guide further management if needed.

Long-term risks

Frequent premature ventricular contractions (PVCs) can lead to arrhythmia-induced cardiomyopathy, a reversible form of left ventricular dysfunction characterized by systolic impairment and dilation, often when the PVC burden exceeds 10% of total beats. This condition arises from dyssynchronous ventricular activation due to high PVC frequency, resulting in adverse remodeling. In patients with high-frequency PVCs, the risk of developing PVC-induced cardiomyopathy increases with burden, with approximately 40% probability over 15 years for burdens >10%. In the general population, frequent PVCs are associated with increased mortality, including a doubled risk of cardiac death as demonstrated in a 2013 meta-analysis of observational studies, which reported an adjusted relative risk of 2.64 for sudden cardiac death in individuals with frequent PVCs compared to those without. This elevated risk persists even in the absence of structural heart disease, highlighting PVCs as an independent prognostic factor for cardiovascular events over long-term follow-up. Progression from PVCs to more malignant ventricular arrhythmias, such as (VT) or (VF), is rare in idiopathic cases without structural heart disease, where the prognosis remains favorable. However, the risk is substantially higher in patients with underlying structural heart disease, where PVCs may serve as triggers for sustained VT or VF, potentially leading to sudden cardiac . The left ventricular dysfunction in PVC-induced is typically reversible following successful PVC suppression, with normalization of function observed in approximately 68% of cases within 4 months post-ablation and in most patients over a mean of 5 months. This reversibility underscores the importance of early intervention in high-burden cases to prevent chronic progression. For patients with a PVC burden exceeding 10%, regular with annual is recommended to detect subclinical left ventricular dysfunction and guide timely management.

Epidemiology

Overall

Premature ventricular contractions (PVCs) are highly prevalent in the general when assessed using . Studies employing 24-hour Holter have detected at least one PVC in 40% to 100% of apparently healthy individuals without structural heart disease. Frequent PVCs, defined as more than 30 per hour (approximately >1% burden), occur in 1% to 4% of the based on standard , with higher rates observed on extended . In healthy adults, PVC prevalence varies by study cohort and monitoring duration. For instance, 24-hour Holter monitoring identified PVCs in 69% of healthy adults aged 25 to 35 years. In a large screening of U.S. personnel using brief (approximately 48 seconds), the prevalence was notably lower at 0.78%, highlighting the influence of monitoring length on detection. Prevalence correlates strongly with age, remaining rare in younger individuals but rising substantially in older adults. PVCs occur in less than 1% of children under 11 years but increase to 40% to 69% in those over 75 years. Detection rates are higher with prolonged compared to standard 24-hour Holter assessments. Extended ambulatory , such as 14-day recording, nearly doubles the identification of patients with high PVC burden (≥10%) relative to 24-hour alone. Global estimates are primarily derived from populations, showing consistent patterns, though data from other regions remain limited; for example, 24-hour Holter revealed PVCs in 67.7% of Chinese outpatients evaluated for . Recent reviews as of 2025 affirm these trends, with prevalence approaching 100% in elderly individuals on Holter .

Population differences

Premature ventricular contractions (PVCs) exhibit notable variations in prevalence across demographic groups. Studies have shown a higher prevalence in men compared to women, with men demonstrating approximately 1.5 to 2 times greater likelihood of PVCs on electrocardiography. The frequency of PVCs increases linearly with age, reflecting age-related changes in cardiac electrophysiology. In younger adults (ages 20-39), prevalence is around 30%, rising to 68% in those aged 40-59 and exceeding 80% in individuals aged 60-79; among those 75 years or older, the prevalence can reach up to 69% on 24-hour Holter monitoring. Ethnic differences are evident, with higher PVC prevalence observed in compared to individuals, particularly in older age groups where rates may be up to twice as high. This disparity persists after adjusting for factors like and heart disease, as documented in large cohort studies. PVC prevalence is substantially elevated in patients with comorbidities such as and , with odds ratios indicating 1.2 to 2 times higher risk in affected individuals, independent of other variables. Geographically, environmental exposures like fine particulate air pollution (PM2.5) are associated with increased PVC risk ( 1.06-1.08 per standard deviation increase), potentially contributing to variations in across regions with differing pollution levels. Data from non-Western regions remain sparse, limiting broader comparisons.

References

  1. [1]
    Premature ventricular contractions (PVCs) - Symptoms & causes
    Sep 20, 2025 · PVCs are extra heartbeats that can make the heart beat out of rhythm. They are very common and may not be a concern.
  2. [2]
    Premature Ventricular Contractions (PVCs) - Cleveland Clinic
    PVCs are a type of irregular heartbeat. They occur when the electrical signal to start your heartbeat comes from your lower heart chambers.
  3. [3]
    Premature Ventricular Complex - StatPearls - NCBI Bookshelf - NIH
    Feb 16, 2025 · Premature ventricular complexes (PVCs), or premature ventricular contractions, are ectopic heartbeats originating from the ventricles.
  4. [4]
    Premature Ventricular Complexes - Medscape Reference
    Sep 2, 2024 · Ventricular premature complexes (VPCs) are ectopic impulses originating from an area distal to the His Purkinje system. VPCs are the most ...
  5. [5]
    The Ubiquitous Premature Ventricular Complex | Cureus
    Jan 7, 2020 · Ventricular premature beats (VPBs), premature ventricular complexes/contractions (PVCs) ... Historically, PVCs have been considered benign.
  6. [6]
    Premature Ventricular Complex (PVC) - ECG Library Diagnosis - LITFL
    A premature ventricular complex (PVC) is a premature beat arising from an ectopic focus within the ventricles. AKA: ventricular ectopics, ventricular ...Discordance · Example Ecgs · SettingsMissing: fibers myocytes distinction historical naming<|control11|><|separator|>
  7. [7]
    Premature Ventricular Contractions (PVCs ... - Michigan Medicine
    PVCs occur when ventricle contractions beat sooner than the next expected regular heartbeat, often interrupting the normal order of pumping. The extra beat is ...
  8. [8]
    Premature Ventricular Contraction (PVC) Vs ... - Qaly | ECG Reader
    When comparing PVC vs PAC on ECG, the key difference lies in their points of origin. PVCs originate from the ventricles, while PACs originate from the atria.
  9. [9]
    Premature Contractions (PVC & PAC) - Houston Methodist
    Both conditions are caused by premature electrical activation in your heart. This results in premature heart muscle contractions, which trigger extra heartbeats ...
  10. [10]
    Clinical Significance of Idiopathic Frequent Premature Ventricular ...
    Sep 27, 2017 · Premature ventricular complexes (PVCs) in the absence of underlying structural heart disease are often benign. ... Ventricular ectopy as a ...Missing: classification extrasystole issues
  11. [11]
    Premature Ventricular Contractions: Symptoms, Cause, Treatment
    Dec 25, 2023 · PVCs are extra heartbeats that start with an electrical signal in one of the ventricles. If you have PVCs, your heartbeat pattern goes like this:
  12. [12]
    ECG tutorial: Ventricular arrhythmias - UpToDate
    Mar 20, 2024 · There can be many sinus node responses to a PVC. Most commonly, a full compensatory pause follows the PVC. Thus, the RR interval between the QRS ...Missing: features | Show results with:features
  13. [13]
    Evaluation and Management of Premature Ventricular Complexes
    Apr 27, 2020 · Chronic hemodynamic effects after radiofrequency catheter ablation of frequent monomorphic ventricular premature beats. J Cardiovasc ...
  14. [14]
    Premature Contractions ‒ PACs and PVCs
    Sep 24, 2024 · Those that start in the lower chambers are premature ventricular contractions, or PVCs. Watch an animation of a normal heartbeat.Missing: Purkinje fibers myocytes distinction classification extrasystole benign
  15. [15]
    The Ubiquitous Premature Ventricular Complex - PMC - NIH
    Jan 7, 2020 · Premature ventricular complexes (PVCs) are one of the most commonly encountered arrhythmias and are ubiquitous in clinical practice.
  16. [16]
    Management of Premature Ventricular Complexes in the Outpatient ...
    High burden of asymptomatic PVCs (>10%). PVCs that come in quick succession to prior non-PVC beats (so-called close or short, coupled PVCs). Short-coupled ...
  17. [17]
    Premature Ventricular Complexes: Benign versus Malignant - NIH
    1). Commonly patients with symptomatic PVCs present with palpitations, skipped beats, chest discomfort, or lightheadedness.
  18. [18]
    Premature Ventricular Contractions in Athletes: Insight into ...
    May 27, 2022 · PVCs induced by exercise raise concern for underlying diseases including ion channelopathies, myocarditis, cardiomyopathy, or ischemia ...
  19. [19]
    Premature Ventricular Contractions | Cedars-Sinai
    Premature ventricular contractions (PVCs) are a type of abnormal heartbeat. Your heart has 4 chambers: 2 upper atria and 2 lower ventricles.
  20. [20]
    Exercise-Induced Ventricular Ectopy and Cardiovascular Mortality in ...
    Nov 29, 2021 · High-grade PVCs occurring during recovery were associated with long-term risk of cardiovascular mortality in asymptomatic individuals.
  21. [21]
    When Should Premature Ventricular Contractions Be Considered as ...
    Dec 10, 2021 · For this reason, a family history of cardiomyopathy, channelopathy or sudden cardiac death should raise concerns when evaluating children with ...
  22. [22]
    2015 ESC Guidelines for the management of patients with ...
    Aug 29, 2015 · A family history of recurrent premature SUDS or inheritable heart disease represents a 'red flag' that makes familial evaluation strongly ...
  23. [23]
    Premature Ventricular Contraction - Yale Medicine
    What causes premature ventricular contraction? · High caffeine consumption · High anxiety levels · Sleep deprivation · The presence of the stress hormones ...
  24. [24]
    Postprandial premature ventricular contractions provoked by ...
    Nov 1, 2025 · Herein, we report a rare case of reproducible postprandial PVCs provoked by gastric distension after intraoperative oral ingestion of jelly ...Postprandial Premature... · Case Report · Discussion
  25. [25]
    PREMATURE VENTRICULAR CONTRACTIONS - Clinical Advisor
    Jun 3, 2008 · Common triggers include tobacco use, caffeine, alcohol, illegal drugs, anxiety, hypertension, exercise, asthma medications, tricyclic ...Missing: lifestyle stress
  26. [26]
    Which Medicines Might Raise My Heart Rate? - WebMD
    Aug 2, 2024 · Tachycardia, or a fast heart rate, can be caused by many medications, including antibiotics, antidepressants, and even certain supplements.
  27. [27]
    The Role of Hypomagnesemia in Cardiac Arrhythmias - NIH
    Sep 21, 2022 · A low magnesium level has been suggested to increase the number of premature atrial and ventricular contractions in healthy subjects. A small ...
  28. [28]
    Cardiomyopathy in Children: Classification and Diagnosis
    May 28, 2019 · Congenital heart disease is sometimes associated with DCM, given the end-stage consequence of abnormal loading conditions (eg, valvular stenosis ...
  29. [29]
    The Role of Thyroid Diseases and their Medications in ...
    Both hyper and hypothyroidism can cause important alterations in cardiac rhythm, output and contractility as well as vascular resistance and blood pressure.
  30. [30]
    Current Concepts of Premature Ventricular Contractions - PMC - NIH
    For the treatment PVCs, it is important to consider underlying heart disease, the frequency of the PVCs and the frequency and severity of symptoms.Missing: typical | Show results with:typical
  31. [31]
    Pathophysiological Mechanisms of Premature Ventricular Complexes
    May 13, 2020 · This review aims to provide an overview of the potential pathophysiological mechanisms of PVCs and their differentiation.
  32. [32]
    Ablating Premature Ventricular Complexes: Justification ... - NIH
    PVCs related to myocardial scar stem from a slowly conducting protected isthmus within the scar that can cause reentrant beats following unidirectional block.
  33. [33]
    Stochastic spontaneous calcium release events trigger premature ...
    Premature ventricular complexes (PVCs) due to spontaneous calcium (Ca) release (SCR) events at the cell level can precipitate ventricular arrhythmias.
  34. [34]
    Focal gap junction uncoupling and spontaneous ventricular ectopy
    Gap junction expression in these hearts is highly abnormal, with well-circumscribed foci of Cx43-deficient myocytes interspersed throughout an otherwise well- ...
  35. [35]
    Synchronization of Early Afterdepolarizations and Arrhythmogenesis ...
    We studied the effects of the spatial distribution of the cell properties and gap junction coupling on EAD synchronization, PVC formation, and multiple focal ...
  36. [36]
    Prognostic Significance of PVCs and Resting Heart Rate - PMC - NIH
    Our findings support the hypothesis that activation of the sympathetic nervous system is an important factor in the genesis of PVCs and ventricular arrhythmias.Missing: threshold | Show results with:threshold
  37. [37]
  38. [38]
    Differentiating Right- and Left-Sided Outflow Tract Ventricular ...
    Jun 4, 2019 · This review will summarize all of the published 12-lead ECG algorithms used to guide localization of OT ventricular arrhythmias.
  39. [39]
    Diagnosis and Treatment of Idiopathic Premature Ventricular ... - MDPI
    In particular, the RVOT is the most common SOO, harboring 80% of OT-PVCs, whereas up to 20% of OT-PVCs originate from the LVOT and near structures, including ...2. Prevalence And Mechanism · 3.1. Outflow Tract... · 4. Diagnostic Work-Up<|control11|><|separator|>
  40. [40]
    Non-Reentrant Fascicular Tachycardia | Circulation: Arrhythmia and ...
    Oct 11, 2016 · Among 530 idiopathic VT patients who were referred for ablation, we identified 15 (2.8%) with non-reentrant fascicular tachycardia (11 men, ...
  41. [41]
    Differentiation of Papillary Muscle From Fascicular and Mitral ...
    Jun 16, 2015 · Patients with papillary muscle VAs were older and had higher prevalence of left ventricular dysfunction (67% versus 13% of fascicular VA ...
  42. [42]
    Relationship of frequent postinfarction premature ventricular ...
    The results of this study show that PVCs in patients with prior myocardial infarction most often arise within an infarct scar. The site of origin of the PVCs ...
  43. [43]
    2017 AHA/ACC/HRS Guideline for Management of Patients With ...
    Aug 1, 2018 · Structural heart disease*, This term encompasses IHD, all types of cardiomyopathy, valvular heart disease, and adult congenital heart disease.
  44. [44]
    Premature Ventricular Complexes Workup - Medscape Reference
    Sep 2, 2024 · Obtain laboratory studies to evaluate or correctable causes of premature ventricular complexes (PVCs) (also known as ventricular premature complexes [VPCs]),Missing: thyroid | Show results with:thyroid
  45. [45]
  46. [46]
    Idiopathic premature ventricular complexes treatment - NIH
    Aug 2, 2023 · Beta‐blockers (BB) or dihydropyridine calcium channel blockers (CCBs) are still the first choices in the treatment of idiopathic premature ...
  47. [47]
    Flecainide for Idiopathic PVCs & Cardiomyopathy: UNIFLECA Trial
    Mar 29, 2025 · Current guidelines, supported by limited evidence, recommend flecainide for PVCs originating from the ventricular outflow tract (Class IIa).
  48. [48]
    Reappraising Use of Flecainide for Atrial Fibrillation and Ventricular ...
    According to the 2022 ESC guidelines, flecainide is recommended as a class IIa treatment for symptomatic idiopathic PVCs when catheter ablation is not preferred ...1. Introduction · 1.1. Old And New Evidence · 1.1. 2. Flecainide In...<|separator|>
  49. [49]
    Catheter Ablation vs Antiarrhythmic Drug Therapy for Treatment of ...
    Mar 22, 2023 · Finally, radiofrequency catheter ablation (CA) for PVCs has procedural success rates of 80% to 95%; however, these approaches are invasive, and ...
  50. [50]
    Long-Term Follow-Up of Catheter Ablation for Premature Ventricular ...
    Nov 6, 2022 · CA of CC PVCs showed favorable outcomes at long-term follow-up (83.2%), ranging between RVOT and LVOT success rate (88.2% and 80.0%, ...3. Results · 3.3. Study Outcomes And... · 4.1. Pvc Ablation And...
  51. [51]
    Similarly high success and low complication rates of catheter ... - PMC
    May 24, 2023 · Success rates for RVOT and LVOT origin were 98% (46/47 cases) and 97% (38/39 cases) respectively. No significant differences in procedure time ( ...
  52. [52]
    Arrhythmia-Induced Cardiomyopathy: Key Points
    Jun 3, 2024 · PVC-CM is characterized by mild to moderate LV dysfunction, LV enlargement, mild mitral regurgitation, and left atrial enlargement, which ...Missing: features | Show results with:features<|control11|><|separator|>
  53. [53]
    Premature Ventricular Complex–Induced Cardiomyopathy - JACC
    May 20, 2019 · Frequent premature ventricular complexes (PVCs) can cause an often reversible form of cardiomyopathy.
  54. [54]
    Clinical Approach to Patients with Frequent PVCs
    Premature ventricular complexes, or PVCs, are a common clinical problem. While patients may be asymptomatic, typically these PVCs cause sensations of ...
  55. [55]
    The safety of catheter ablation for premature ventricular contractions ...
    Aug 31, 2018 · The overall success rate was 94.1%. The overall complication rate was 2.7%. By multivariate logistic regression analysis, origins of EPI and LV ...Complications · Safety Of Pvcs Ablation · Efficacy Of Ablation
  56. [56]
    Successful catheter cryoablation for premature ventricular ...
    Jun 25, 2019 · We performed catheter cryoablation of PVCs, originating from the para-Hisian region, without causing atrioventricular conduction disturbances.
  57. [57]
    2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on ...
    In symptomatic patients with frequent PVCs from the RVOT, catheter ablation had a higher rate of efficacy than pharmacotherapy with either metoprolol or ...
  58. [58]
    Premature ventricular contractions (PVCs) - Diagnosis & treatment
    Sep 20, 2025 · It can diagnose PVCs. Sticky patches with sensors on them go on the chest and sometimes the arms and legs. Wires connect the sensors to a ...
  59. [59]
    Multicenter Outcomes for Catheter Ablation of Idiopathic Premature ...
    This study is the first large-scale, multicenter analysis of outcomes of ablation of idiopathic PVCs. The overall acute success rate of PVC ablation was 84%.
  60. [60]
    Premature Ventricular Contractions | Circulation
    Aug 19, 2019 · In patients who are asymptomatic with a higher PVC burden, we typically recommend repeat monitoring, including echocardiography and rhythm ...Missing: techniques | Show results with:techniques
  61. [61]
    Premature ventricular contractions: Reassure or refer?
    Jul 1, 2016 · A right bundle branch block pattern PVC does not imply the presence of underlying structural heart disease. PVCs may arise from both the ...Abstract · Initial Evaluation · Idiopathic Pvcs
  62. [62]
    Meta-analysis of ventricular premature complexes and their relation ...
    Oct 15, 2013 · The overall adjusted relative risk for sudden cardiac death comparing participants with frequent VPCs versus those without frequent VPCs was ...
  63. [63]
    Ventricular Arrhythmias in the Absence of Structural Heart Disease
    May 7, 2012 · The overwhelming majority of VAs in patients without structural heart disease carry an excellent prognosis, and include premature ventricular ...
  64. [64]
    Recovery from left ventricular dysfunction after ablation of ... - PubMed
    PVC-induced cardiomyopathy resolves within 4 months of successful ablation in most patients. In about one-third of the patients, recovery is delayed and can ...Missing: reversibility 80-90%
  65. [65]
    Premature Ventricular Contractions (PVCs) - DynaMed
    Jun 28, 2024 · The most common origin of PVCs is the right ventricular outflow tract (RVOT) in patients without structural heart disease and the left ventricle ...
  66. [66]
    The Influence of Lifestyle Factors on the Occurrence and Severity of ...
    Caffeine and drugs precipitate heightened cardiac stimulation, precipitating PVCs. Excessive alcohol and nicotine disturb the electrical pathways resulting in ...
  67. [67]
    Premature Ventricular Contraction-Induced Cardiomyopathy
    Feb 1, 2012 · They may cause troubling and sometimes incapacitating symptoms such as palpitations, chest pain, presyncope, syncope, and heart failure.
  68. [68]
    Longer Ambulatory ECG Monitoring Increases Identification of ...
    Most patients with PVC burdens ≥20% were detected with 24 hours of monitoring, extended monitoring nearly doubled the identification of those reaching the 10% ...
  69. [69]
    Prevalence and heart rate variability characteristics of ... - BMJ Open
    The prevalence of PVC and frequent PVCs were 67.7% and 7.7%, respectively, detected by 24-hour Holter among Chinese outpatients with palpitations.24-Hour Holter Monitoring · Prevalence Of Pvc Detected... · Pvc Burden And Lv Systolic...<|control11|><|separator|>
  70. [70]
    The effect of age, blood pressure and gender on the ... - PubMed
    On the contrary, apparently normal (Group I) men had almost twice the PVC prevalence (74.6% vs. 41.1%, p less than 0.001) and complexity (20.1% vs. 10.1%, p ...
  71. [71]
    the Atherosclerosis Risk in Communities (ARIC) study - PubMed - NIH
    Conclusions: The prevalence of PVCs on a 2-minute ECG differs by age, ethnicity, and sex and is associated with hypertension, heart disease, faster sinus rates, ...
  72. [72]
    Premature ventricular beats in healthy adult subjects 20 to 79 years ...
    The prevalence of PVBs increased significantly with age: 31, 68 and 84% in the respective age groups: 20-39, 40-59 and 60-79 (P less than 0.05).Missing: contractions | Show results with:contractions
  73. [73]
    Mechanisms and Risk Factors for Premature Ventricular Contraction ...
    The prevalence is up to 69% in individuals aged 75 years or older, while it is lower than 1% in children aged 0–11 years. PVCs are generally considered to be ...
  74. [74]
    The Atherosclerosis Risk in Communities (ARIC) study - ScienceDirect
    Prevalence of premature ventricular contractions in a population of African American and white men and women: The Atherosclerosis Risk in Communities (ARIC) ...
  75. [75]
    Premature ventricular contraction is associated with increased risk of ...
    Jan 15, 2021 · In our cohort, people with PVC were older and had higher prevalence of hypertension and diabetes, which are all risk factors associated with AF.
  76. [76]
    Fine Particulate Air Pollution and Premature Ventricular Contractions
    Our findings suggest that PM 2.5 exposure is associated with an increased risk for PVCs in a biracial population-based study of men and women.